Fred Bunz

10.5k citations

58 papers · 8.7k indexed · 3 hit papers · h-index 32

Impact in

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Oncology top 0.5%
- Cancer-related Molecular Pathways

Papers in

Cancer Research 16
- Carcinogens and Genotoxicity Assessment 7
Oncology 28
- Cancer-related Molecular Pathways 25

Co-authors: Bert Vogelstein Kenneth W. Kinzler Christoph Lengauer Todd Waldman Annie Dutriaux John M. Sedivy Paul M. Hwang Steven Zhou
Journals: Proceedings of the National Academy of Sciences (5 papers)Cell Cycle (5 papers)Cancer Biology & Therapy (4 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Fred Bunz

56 papers receiving 8.5k citations

Hit Papers

align trajectories log scale

p53 Regulates Mitochondrial Respiration 2006 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Science
1999 Journal of Clinical Investigation
1998 Science

Peers

Countries citing papers authored by Fred Bunz

Since Specialization

Citations

This map shows the geographic impact of Fred Bunz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Bunz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Bunz more than expected).

Fields of papers citing papers by Fred Bunz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Bunz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Bunz. The network helps show where Fred Bunz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fred Bunz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fred Bunz Line = papers co-authored together Fred Bunz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Interferons in Colorectal Cancer Pathogenesis and Therapy PubMed ·Fernandez Paloma, Fred Bunz	2024	0
2	Tumor suppressor genes The biomedical & life sciences collection. ·Fred Bunz	2021	4
3	Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia International Journal of Hyperthermia ·Anirudh Sharma, RanumDavid, Julia S. Caserto, Rosemarie ten Cate, Nicole M. Anders, James D. Barnett, Sri Kamal Kandala, Elizabeth Henderson, Jacqueline Stewart, Eleni Liapi, Michelle A. Rudek, Nicolaas A.P. Franken, Arlene L. Oei, Preethi Korangath, Fred Bunz, Robert Ivkov	2019	22
4	Seamless assembly of recombinant adenoviral genomes from high-copy plasmids PLoS ONE ·韦端, V. A. Petukhov, Fred Bunz	2018	16
5	Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor Molecular Cancer Therapeutics ·欣也水口, Ren-Yuan Bai, Jon Chung, Alexandra Borodovsky, Charles M. Rudin, Gregory J. Riggins, Fred Bunz	2014	75
6	Transcriptomes and shRNA Suppressors in a TP53 Allele–Specific Model of Early-Onset Colon Cancer in African Americans Molecular Cancer Research ·Molina Sánchez A, Marc R. Birtwistle, Himel Mallick, Nengjun Yi, Amitav Ghosh, Gözde Demirci, Larry A. Campagna, Osigwe Ugochukwu, D ATCHLEY, Christine M. Pacold, Christopher Farrell, Fred Bunz, Hao Ji, Michael Shtutman, Kim E. Creek, Carolyn E. Banister, Phillip Buckhaults	2014	12
7	Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis Neuro-Oncology ·Ren-Yuan Bai, Verena Staedtke, Charles M. Rudin, Fred Bunz, Gregory J. Riggins	2014	74
8	Targeted Mutations in the ATR Pathway Define Agent-Specific Requirements for Cancer Cell Growth and Survival Molecular Cancer Therapeutics ·Deborah Wilsker, Jon Chung, Iván Pradilla, Eva Petermann, Thomas Helleday, Fred Bunz	2011	4
9	Cdk2 Is Required for p53-Independent G2/M Checkpoint Control PLoS Genetics ·Jon Chung, Fred Bunz	2010	85
10	A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53 Proceedings of the National Academy of Sciences ·Surojit Sur, Raymond Pagliarini, Fred Bunz, Carlo Rago, Luis A. Díaz, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos	2009	230
11	Chk1 phosphorylation during mitosis: A new role for a master regulator Cell Cycle ·Deborah Wilsker, Fred Bunz	2009	6
12	RNAi -Mediated Silencing of Nuclear Factor Erythroid-2–Related Factor 2 Gene Expression in Non–Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy Cancer Research ·Anju Singh, Swetlana Boldin‐Adamsky, Rajesh K. Thimmulappa, Srikanta Kumar Rath, Hagit Ashush, Jonathan B. Coulter, Amanda L. Blackford, Steven N. Goodman, Fred Bunz, Walter H. Watson, Edward Gabrielson, Elena Feinstein, Shyam Biswal	2008	313
13	Deficiency of Bloom syndrome helicase activity is radiomimetic Cancer Biology & Therapy ·David P. Horowitz, Özlem Topaloglu, Yonggang Zhang, Fred Bunz	2008	3
14	Epitope tagging of endogenous genes in diverse human cell lines Nucleic Acids Research ·Gurnoor Singh, Challice L. Bonifant, Fred Bunz, W S Lane, Todd Waldman	2008	29
15	Genetic knockouts and knockins in human somatic cells Nature Protocols ·Carlo Rago, Bert Vogelstein, Fred Bunz	2007	98
16	p53 Regulates Mitochondrial Respiration Science ·Satoaki Matoba, Ju‐Gyeong Kang, Willmar D. Patino, Andrew Wragg, Manfred Boehm, Oksana Gavrilova, Paula J. Hurley, Fred Bunz, Paul M. Hwang Hit paper breakdown →	2006	1327
17	Human cancer cells require ATR for cell cycle progression following exposure to ionizing radiation Oncogene ·Paula J. Hurley, Deborah Wilsker, Fred Bunz	2006	47
18	Human cell knockouts Current Opinion in Oncology ·Fred Bunz	2002	15
19	Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells Nature Medicine ·Paul M. Hwang, Fred Bunz, Jian Yu, Carlo Rago, Timothy A. Chan, Michael P. Murphy, Rafael Peñafiel Ona, Robin A.J. Smith, Kenneth W. Kinzler, Bert Vogelstein	2001	352
20	Disruption of p53 in human cancer cells alters the responses to therapeutic agents Journal of Clinical Investigation ·Fred Bunz, Paul M. Hwang, Chris Torrance, Todd Waldman, Yonggang Zhang, Larry E. Dillehay, Jerry Williams, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein Hit paper breakdown →	1999	883

About Fred Bunz

Fred Bunz is a scholar working on Cancer Research, Oncology, Cell Biology, Molecular Biology and Genetics, having authored 58 papers that have together received 8.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (25 papers), DNA Repair Mechanisms (24 papers), Microtubule and mitosis dynamics (10 papers), Carcinogens and Genotoxicity Assessment (7 papers), Cell death mechanisms and regulation (6 papers), Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (3.7k citations), Molecular Biology (6.6k citations), Cell Biology (1.2k citations) and Biotechnology (639 citations). Fred Bunz has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Christoph Lengauer, Todd Waldman, Annie Dutriaux, John M. Sedivy, Paul M. Hwang, Steven Zhou, Jeremy Brown and Paula J. Hurley. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell Cycle, Cancer Biology & Therapy, Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact